 Mechanism inhibitory action prostaglandins growth human gastric carcinoma cell line KATO III Prostaglandins PGs important roles regulation various gastric functions study effects various PGs growth human gastric carcinoma cell line KATO III PGs inhibited KATO III cell growth relative potency order ester ornoprostil alpha inhibition increase cyclic adenosine monophosphate production Furthermore presence guanosine triphosphate PGs adenylate cyclase activity plasma membrane KATO III cells enhancement membrane guanosine triphosphatase activity relative potencies PGs cyclic adenosine monophosphate levels adenylate cyclase guanosine triphosphatase activity comparable cell growth hand proliferation KATO III cells forskolin dibutyryl cyclic adenosine monophosphate none agents cyclic adenosine monophosphate levels effect results PGs inhibit KATO III cell growth cyclic adenosine monophosphate production guanosine triphosphate-dependent process involvement guanosine triphosphate-binding stimulatory protein receptors action PGs